Volume 16, Number 3—March 2010
Dispatch
Quinine-Resistant Malaria in Traveler Returning from Senegal, 2007
Bruno Pradines, Thierry Pistone, Khaled Ezzedine
, Sébastien Briolant, Lionel Bertaux, Marie-Catherine Receveur, Daniel Parzy, Pascal Millet, Christophe Rogier, and Denis Malvy
, Sébastien Briolant, Lionel Bertaux, Marie-Catherine Receveur, Daniel Parzy, Pascal Millet, Christophe Rogier, and Denis Malvy
Table
In vitro susceptibility of 3 Plasmodium falciparum isolates to 12 antimalarial drugs, France*
| Drug | 50% Inhibitory concentration |
|||
|---|---|---|---|---|
| Study isolate | 3D7 | W2 | Cutoff value | |
| Quinine | 829 nmol/L | 157 nmol/L | 574 nmol/L | >800 nmol/L |
| Chloroquine | 472 nmol/L | 21 nmol/L | 392 nmol/L | >100 nmol/L |
| Mefloquine | 10.4 nmol/L | 49.3 nmol/L | 39.3 nmol/L | >30 nmol/L |
| Lumefantrine | 19 nmol/L | 29 nmol/L | 35 nmol/L | >150 nmol/L |
| Monodesethylamodiaquine | 47 nmol/L | 17 nmol/L | 162 nmol/L | >80 nmol/L |
| Dihydroartemisinin | 1.1 nmol/L | 2.5 nmol/L | 3.0 nmol/L | >10.5 nmol/L |
| Atovaquone | 13.3 nmol/L | 4.1 nmol/L | 3.6 nmol/L | >350 nmol/L |
| Cycloguanil | 70 nmol/L | <10 nmol/L | 1191 nmol/L | >500 nmol/L |
| Pyrimethamine | 354 nmol/L | <50 nmol/L | 9139 nmol/L | >2,000 nmol/L |
| Doxycycline | 12.8 μmol/L | 10.5 μmol/L | 13.5 μmol/L | >35 μmol/L |
| Azithromycin | 24 μmol/L | 48 μmol/L | 39 μmol/L | ND |
| Clindamycin | 39 μmol/L | 108 μmol/L | 126 μmol/L | ND |
*P. falciparum strains 3D7 and W2 were used as controls. ND, not determined.
Page created: December 14, 2010
Page updated: December 14, 2010
Page reviewed: December 14, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.